The most common question regarding immune globulin (Ig) products relates to whether they are all the same. Even though clinicians have considered all Ig products to be clinically equivalent, they are not pharmaceutically equivalent.
JANUARY, 2010

For patients receiving chemotherapy, febrile neutropenia often is associated with immediate hospitalization and institution of empiric broadspectrum antibiotic therapy. Although the condition remains a major source of morbidity and mortality, improvements in treatment have significantly improved outcomes.
DECEMBER, 2009

Hyponatremia, a common electrolyte imbalance, generally is defined as a serum sodium concentration of less than 135 mEq/L. Patients with acute or moderate to severe hyponatremia may present with neurologic signs and symptoms and may be at risk for long-term complications. However, even patients with mild, chronic forms of the disorder may be at risk for significant morbidity, making recognition and appropriate treatment essential.
NOVEMBER, 2009

Treatment selection for Clostridium difficile infection (CDI) has become more complex despite the lack of new FDA-approved treatments. The challenge of managing these patients is due, in part, to the growing prevalence and severity of the disease. Fortunately, algorithms based on the severity of illness can help clinicians choose among currently available medications. And several investigational agents show promise for reducing the high rate of CDI recurrence.
OCTOBER, 2009

The most common question regarding immune globulin (Ig) products relates to whether they are all the same. Even though clinicians have considered all Ig products to be clinically equivalent, they are not pharmaceutically equivalent.
OCTOBER, 2009

The prevention of medication errors is an essential requirement for pharmaceutical care and must be a core mission of every pharmacy. If efforts to prevent medication errors are to be effective and successful, they must become a priority.
OCTOBER, 2009

The American Society of Clinical Oncology,1 the European Society of Medical Oncology,2 the Multinational Association of Supportive Care in Cancer,3 and the National Comprehensive Cancer Network4 have all recently published antiemetic guidelines.
OCTOBER, 2009

Malnutrition is associated with an increased frequency of treatment complications and length of stay in the intensive care unit (ICU) and hospital, as well as increased costs of medical care. Patients at high risk for malnutrition should be identified and evaluated for specialized nutrition support (SNS).
OCTOBER, 2009